GLP-1 Anesthesia: What to Know Before Surgery (October 2026)

01 · The core answer

GLP-1 and anesthesia: what you actually need to know

The short answer is that GLP-1 treatment is relevant to anesthesia because it slows digestion. Mounjaro (tirzepatide) activates the GIP and GLP-1 receptors, and the product information describes this as helping regulate appetite, slowing how quickly the stomach empties and improving how the body responds to insulin.¹ Slower stomach emptying is a useful part of how the medicine works day to day. Before a procedure that needs you unconscious or sedated, it is a point your anaesthetic team wants to weigh up.

That is the whole reason behind the headlines. The worry is not that the medicine is unsafe to take, and it is not that it reacts with anaesthetic drugs in some dramatic way. It is that an empty stomach is the normal assumption behind pre-operative fasting, and a medicine that slows emptying can make that assumption less certain. Your anaesthetist is the person who decides how to handle it.

The same logic applies whichever GLP-1 medicine you use. Mounjaro and Wegovy are once-weekly injections, while liraglutide products such as Saxenda are daily injections. Whatever the brand or schedule, name it, give the dose and say when you last injected.

02 · Your decisions

The decisions you are really facing

Most readers face two practical decisions: how to tell the team, and whether anything about your treatment should change. The first is entirely in your hands. The second is not.

Telling the team is simple. Say it at pre-assessment, repeat it on the day, and mention it again to the anaesthetist who meets you. Do not assume the information has travelled between departments, and do not assume it is unimportant because your GP or an online pharmacy already knows. Our guide to Mounjaro and general anesthesia goes into the same topic from the Mounjaro side.

Changing treatment is a clinical call. Some people are asked to adjust or pause an injection beforehand, and some are given specific fasting or diet instructions. A missed injection, or stopping unsupervised, can affect your treatment plan, and it may not give the surgical team what they were hoping for anyway. Ask them directly.

If you already take Mounjaro and are looking at how it fits your wider plan, our weight loss clinic page explains how treatment and reviews work.

03 · Why stomach emptying matters

Why stomach emptying matters under anesthesia

General anesthesia reduces the protective reflexes that normally keep stomach contents out of the airway. This is the reason you are asked to fast before a planned operation: an empty stomach leaves little to come back up.

GLP-1 medicines complicate that picture. The product information for Mounjaro describes slower stomach emptying as part of how tirzepatide works.¹ If digestion is slower, then fasting for the usual period may not always mean the stomach is as empty as the team would expect. That uncertainty is what the anaesthetist is trying to manage.

It helps to be clear about what this is and is not. It is a reason for the team to plan carefully, to ask you questions and sometimes to adapt their approach. It is not a reason to panic, and it is not a reason to hide your treatment. Teams can only adjust for what they know, and the most avoidable problem is a medicine that nobody mentioned.

You may notice that you feel full for longer after meals, or that nausea is more likely after you raise your dose. Those day-to-day effects are linked to the same mechanism. If you have had persistent fullness, nausea or vomiting in the days before a procedure, mention that too, because it is information the anaesthetist can use. The patient information leaflet lists the side effects to look out for and what to do about them.¹³

The words you may see in clinical writing are aspiration, meaning stomach contents entering the lungs, and residual gastric contents, meaning food or fluid still in the stomach. You do not need to use that language yourself. Plain wording works: I inject a GLP-1 medicine every week, my last dose was on this day, and I would like to know whether I need to do anything differently.

04 · General, local and sedation

General anesthesia, local anesthesia and sedation

The type of anesthesia matters. The concern described above is tied to anything that reduces your alertness or airway protection, which is why general anesthesia gets the most attention. Sedation sits in between and is often discussed in the same breath.

Local anesthesia, such as a numbing injection for a dental procedure or a small skin procedure, leaves you awake. People often ask whether GLP-1 treatment changes how local anesthetic works. The sensible position is the same as for every other procedure: mention the medicine, and let the clinician who is treating you decide whether it changes anything.

Dentists, podiatrists and cosmetic clinicians are not always asked to consider injectable weight-loss treatment, so people sometimes leave it off the form. Please include it on every medicines list. If a procedure could move to sedation or general anesthesia at short notice, say so at the start, because the team may prefer to know before the day rather than during it.

If you want a related read written specifically around the medicine, see Mounjaro and anesthesia, and for a question-led take, can Mounjaro affect anesthesia.

05 · What to tell your team

What to tell your surgical team

Give the team the full picture of your treatment, because partial detail is hard to act on. A short, specific list works best.

• The medicine name: Mounjaro (tirzepatide), Wegovy (semaglutide), a liraglutide product, or another GLP-1 medicine.
• Your current dose: for Mounjaro this is one of 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg or 15mg, and for Wegovy 0.25mg, 0.5mg, 1mg, 1.7mg or 2.4mg.
• When you last injected: the day matters more than the time, and liraglutide is daily whereas Mounjaro and Wegovy are weekly.
• Whether you are still increasing the dose: titration is when digestive side effects are usually most noticeable, so say if you recently stepped up.
• Any digestive symptoms: nausea, vomiting, bloating, constipation or fullness that lingers.
• Other medicines: especially insulin, sulfonylureas and oral contraceptives, because these have their own considerations alongside GLP-1 treatment.

If you take insulin or a sulfonylurea, doses may need adjusting because of the risk of low blood sugar, and that conversation is worth having before any fasting period. Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.

Bring your pen box or a photo of the label if you can. Many people find it easier than reciting details from memory when they are nervous.

06 · Should I stop my injection?

Should you stop your injection before surgery?

Do not decide this alone. Whether to pause, delay or continue a dose before surgery is a joint decision between your anaesthetist and the prescriber who looks after your treatment. Different hospitals and different procedures lead to different answers.

Understanding the timing helps you ask better questions. Tirzepatide is a once-weekly medicine and takes four to five weeks to clear the system after a final dose. There is no way to speed that up, and nothing needs doing while it clears.¹ That means skipping a single weekly injection does not remove the medicine from your body in the way that skipping a short-acting tablet might. It is one reason clinicians talk about planning rather than last-minute changes.

Good questions to ask at pre-assessment include:

• Do you want me to change anything about my injection before this procedure?
• Will I get specific fasting or diet instructions, and are they different because of my medicine?
• Who should I contact if I have nausea or vomiting before the day?
• How and when should I restart afterwards?

If you are told to miss or delay a dose, tell your prescriber so your plan can be reviewed. Restarting after a break, particularly a longer one, is also a prescriber decision, because the right dose to resume at depends on your situation. Please do not restart at a high dose on your own after any gap. Our article on GLP-1 adherence looks at keeping treatment on track around life events such as procedures.

07 · Planned vs emergency surgery

Planned and emergency procedures

With a planned operation you have time to prepare. Pre-assessment is the moment to raise your treatment, and the earlier you do it, the more room the team has to plan. Do not wait for the day itself. If a date has been set and you have not yet been asked about medicines, contact the department.

With emergency surgery or an unplanned procedure there is no time for preparation, so the information you give matters even more. If you can speak, say that you take a GLP-1 medicine and when you last injected. If you cannot, a note in your phone, a medicines list in your wallet or a family member who knows can fill the gap. Teams treating an emergency will assume the stomach may not be empty if they cannot confirm otherwise, and that is a reasonable way to protect you.

The simplest rule is the same in both cases: tell them, every time.

It also helps to keep your own records current. The free GLPTrackr companion app lets you log doses and dates, which makes it easy to say exactly when you last injected. Our piece on GLP-1 technology covers tools like this in more depth.

08 · Other GLP-1 medicines

Wegovy, liraglutide and other GLP-1 medicines

The advice to tell your team applies across the whole group. Wegovy (semaglutide) is a once-weekly injection with a dose ladder of 0.25mg, 0.5mg, 1mg, 1.7mg and 2.4mg, with titration stepping up after at least four weeks and reaching the 2.4mg maintenance dose from week 17. Liraglutide, sold as Saxenda and in other products, is supplied at a concentration of 6mg per millilitre and is a daily injection. Mounjaro is a different molecule that acts on both GIP and GLP-1 receptors.

The Mounjaro information describes how the dual action differs from single-action GLP-1 medicines such as semaglutide.¹ Treat them all the same way when you speak to your team.

If you are weighing up treatment options generally, a free consultation with a GPhC-registered prescriber can help you choose.

Tablets and newer oral GLP-1 medicines are described in their own product information. If you take one, check its leaflet and tell your team the name in the same way.

09 · Common myths

Common myths worth correcting

Myth: it is only a concern for people with diabetes. The mechanism relates to the medicine, not the reason you take it. Mounjaro is licensed for weight management and for type 2 diabetes, and both groups should tell their team.

Myth: if I fasted properly, it makes no difference. Fasting is the standard approach, but a medicine that slows stomach emptying is exactly why teams ask extra questions even when you have followed instructions.

Myth: I should hide it so the operation is not cancelled. The opposite is true. Delay or a change of plan is far better than a surprise during anesthesia. Teams would rather adapt than cancel without warning, and concealment removes their options.

Myth: stopping the injection yesterday solves it. Tirzepatide takes four to five weeks to clear, so a last-minute pause does not work the way people expect, and any decision should be made with your clinicians.

Myth: it is a scam or a fad, so it will not be on the list. Treatment is a licensed medicine and belongs on your medicines list. If you want context on that debate, see is GLP-1 a con.

10 · Safety, reporting and aftercare

Safety, reporting and aftercare

If anything unexpected happens around a procedure, tell the team looking after you, then tell your prescriber. If you think a symptom or reaction could be linked to your medicine, you can report it through the MHRA Yellow Card scheme.¹⁹ Reports help regulators spot patterns, and you do not need to be certain of the cause to report.

After a procedure, some people feel more nauseous or have a reduced appetite because of the operation, the anesthetic or pain relief, and it can be difficult to separate that from the effect of the medicine. Keep your prescriber informed about how you are eating and drinking, and ask the surgical team when it is appropriate to restart your injection. Do not assume you can simply resume where you left off.

Our support team is available Monday to Friday, 9am to 5pm, on 0333 207 0413 or at support@everydaymeds.co.uk if you want to flag an upcoming procedure and ask us to pass information to your prescriber. We are not a substitute for your surgical team, and the decisions about anesthesia belong to them.

Mounjaro is a prescription-only medicine supplied only after a consultation. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary, and this page is information, not a substitute for medical advice.

11 · Planning ahead

Planning ahead if you take Mounjaro

Simple organisation is the best preparation. Keep an up-to-date list of your medicines, including the dose and the date of your last injection. Mention your treatment at every appointment where sedation or anesthesia is possible, including dental, endoscopy and day-surgery settings. If a date is booked, speak to your prescriber early so that any change to your plan can be discussed without pressure.

If you are due to step up in dose around the time of a procedure, ask whether the timing should change. Dose increases happen on a schedule set by your prescriber, and our regular reviews are a good place to raise this. Finish your questions before the day, because pre-operative nerves make it harder to remember them later.

Wherever you get your treatment, keep the box, keep your records, and keep your clinicians informed.

12 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.¹